Association Between MTHFR C677T Polymorphism and Venous Thromboembolism Risk in the Chinese Population: A Meta-Analysis of 24 Case-Controlled Studies

Angiology

Volumn 66, Issue 5, 2015, Pages 422-432

  Zhang, Peijin ^a   Gao, Xiuyin ^a   Zhang, Yanyan ^a   Hu, Yuewen ^a   Ma, He ^a   Wang, Wei ^a   Wang, Hui ^a   Zhang, Jing ^a   Xu, Hao ^a   Lu, Zhaojun ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chinese population; meta analysis; MTHFR C677T; venous thromboembolism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ARTICLE; CHINESE; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LUNG EMBOLISM; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY ANALYSIS; SPLANCHNIC VEIN THROMBOSIS; SYSTEMATIC REVIEW; VENOUS THROMBOEMBOLISM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHINA; ENZYMOLOGY; EPIDEMIOLOGY; ETHNOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PHENOTYPE; RISK;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84928040724     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714546368     Document Type: Article

References (50)

1. Arfvidsson B, Eklof B, Kistner RL, Masuda EM, Sato DT. Risk factors for venous thromboembolism following prolonged air travel. Coach class thrombosis. Hematol Oncol Clin North Am. 2000 ; 14 (2). 391-400, ix
2. Khare A, Ghosh K, Kulkarni B, Mohanty D. Thrombophilia: hereditary and acquired in cardiovascular disease. Haematologia. 2002 ; 32 (4). 293-311
3. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007 ; 44 (2). 62-69
4. Rogers EJ, Chen S, Chan A. Folate deficiency and plasma homocysteine during increased oxidative stress. N Engl J Med. 2007 ; 357 (4). 421-422
5. Goyette P, Sumner JS, Milos R, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet. 1994 ; 7 (2). 195-200
6. Goyette P, Pai A, Milos R, et al. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome. 1998 ; 9 (8). 652-656
7. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995 ; 10 (1). 111-113
8. Simone B, De Stefano V, Leoncini E, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013 ; 28 (8). 621-647
9. Jang MJ, Jeon YJ, Choi WI, et al. The 677C > T mutation of the MTHFR gene increases the risk of venous thromboembolism in Koreans and a meta-analysis from Asian population. Clin Appl Thromb Hemost. 2013 ; 19 (3). 309-314
10. Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost. 2009 ; 102 (2). 360-370
11. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000 ; 283 (15). 2008-2012
12. Qin X, Peng Q, Chen Z, et al. The association between MTHFR gene polymorphisms and hepatocellular carcinoma risk: a meta-analysis. PloS One. 2013 ; 8 (2). e56070
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003 ; 327 (7414). 557-560
14. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 ; 21 (11). 1539-1558
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trial. 1986 ; 7 (3). 177-188
16. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 ; 22 (4). 719-748
17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 ; 315 (7109). 629-634
18. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 ; 50 (4). 1088-1101
19. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000 ; 56 (2). 455-463
20. Zheng YZ, Tong J, Do XP, Pu XQ, Zhou BT. Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population. Br J Haematol. 2000 ; 109 (4). 870-874
21. Yin G, Yan L, Zhang Z, Chen K, Jin X. C677T methylenetetrahydrofolate reductase gene polymorphism as a risk factor involved in venous thromboembolism: a population-based case-control study. Mol Med Rep. 2012 ; 6 (6). 1271-1275
22. Lu Y, Zhao Y, Liu G, et al. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res. 2002 ; 106 (1). 7-12
23. Lin JS, Shen MC, Tsai W, Lin B. The prevalence of C677T mutation in the methylenetetrahydrofolate reductase gene and its association with venous thrombophilia in Taiwanese Chinese. Thromb Res. 2000 ; 97 (3). 89-94
24. Li XM, Wei YF, Hao HL, et al. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome. Am J Hematol. 2002 ; 71 (1). 11-14
25. Hsu TS, Hsu LA, Chang CJ, et al. Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study. Thromb Res. 2001 ; 102 (5). 387-395
26. Hsu LA, Ko YL, Wang SM, et al. The C677T mutation of the methylenetetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan. Hum Hered. 2001 ; 51 (1-2). 41-45
27. Ho CH. Prevalence of prothrombin 20210A allele and methylenetetrahydrofolate reductase C677T genetic mutations in the Chinese population. Ann Hematol. 2000 ; 79 (5). 239-242
28. He JA, Hu XH, Fan YY, et al. Hyperhomocysteinaemia, Low folate concentrations and methylene tetrahydrofolate reductase C677T mutation in acute mesenteric venous thrombosis. Eur J Vasc Endovasc Surg. 2010 ; 39 (4). 508-513
29. Gao W, Wang YS, Zhang P, Wang HY. MTHFR C677T mutation in central retinal vein occlusion: a case-control study in Chinese population. Thromb Res. 2008 ; 121 (5). 699-703
30. Dong N, Wang B, Chu L, Xiao L. Plasma homocysteine concentrations in the acute phase after central retinal vein occlusion in a Chinese population. Curr Eye Res. 2013 ; 38 (11). 1153-1158
31. Yu Hd, Zheng H, Qi H, Lian Jh, He Y, Dong Zm. Study on the association of polymorphisms in homocysteine metabolism related enzymes with deep venous thrombosis. Chin J Med Genet. 2006 ; 23 (6). 635-639
32. Wang M-t, Li Q, Han F-l, Yao X-p. Relationship of plasma homocysteine and folic acid levels and 5,10-methylenetetrahydrofolate reductase gene mutation with venous thromboembolism. Chinese J Intern Med. 2004 ; 43 (8). 591-594
33. Qiu L, Yan Sk, Song Yh. Hyperhomocysteinemia and deep-vein thrombosis. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae. 2003 ; 25 (6). 706-709
34. Guo C, Guo Q, Gong Y, et al. The C677T mutation in the methylenetetrahydrofolate reductase gene and its association with deep vein thrombophilia in Shandong Hans. Chin J Med Genet. 2002 ; 19 (4). 295-297
35. Kailibinuer A, Mahemuti A, Xia Y-n, Hu X-m. Association between gene polymorphisms of methylenetetrahydrofolate reductase and plasma homocysteine in Uygur patients with venous thromboembolism. Zhonghua Xin Xue Guan Bing Za Zhi. 2012 ; 40 (12). 1030-1036
36. Zhu DX. Relationship between methylene tetrahydrofolate reductase gene, angiotensin coverting enzyme gene golymorphisms and lowerextremity deep venous thrombosis. 2008. http://new.med.wanfangdata.com.cn/Paper/Detail?id=DegreePaper-Y1333624.
37. Zhou YB, Xu K, Liu RB, Xiao L. An association study of methylenetetrahydrofolate reductase gene polymorphism with deep venous thrombosis. Chin J Thromb Hemost. 2003 ; 9 (2). 52-55
38. Zhou WM. Relationship between genetic polymorphism of MTHFR C677T and lower extremeities deep venous thrombosis. J Nanchang University Medical Science. 2010 ; 12 (50). 70-73
39. Ye YP, Wang C, Liu YM, Huang XX, Pang BS. Relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and hyperhomocysteinmia and pulmonary thromboembolism. J Capital Univ Med Sci. 2004 ; 25 (03). 321-325
40. Wang XD, Zhang DX. The association of the cholesteryl ester transfer protein TaqIB and methylenetetrahydrofolate reductase C677T polymorphism with central retinal vein occlusion. Shaanxi Med J. 2011 ; 40 (10). 1352-1354
41. Tian H, Xu H, Zu MH, Pei DS. Correlation of MTHFR C677T gene polymorphism plasma and Hcy levels in young patients with hepatic vein obstruction. J Intervent Radiol. 2012 ; 21 (01). 62-65
42. Mei L. Methylenetetrahydrofolate reductase gene poly morphism and deep-vein thrombosis. Chin Foreign Med Res. 2010 ; 19 (08). 21-22
43. Lin SR, Cai XH, Liu QC. Correlection between methylenetetrahydrofolate reductase C677T polymorphism and deep venous thrombosis in Han population of Fujian province. J Shaanxi Coll Trad Chin Med. 2009 ; 10 (1). 45-46
44. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig ML. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nature Struct Biol. 1999 ; 6 (4). 359-365
45. Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost. 2005 ; 3 (2). 292-299
46. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000 ; 151 (9). 862-877
47. De Marco P, Calevo MG, Moroni A, et al. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet. 2002 ; 47 (6). 319-324
48. Pepe G, Camacho Vanegas O, Giusti B, et al. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet. 1998 ; 63 (3). 917-920
49. Klerk M, Verhoef P, Clarke R, et al. MTHFR 677C - >T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 2002 ; 288 (16). 2023-2031
50. Quinlivan EP, Gregory JF III. Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr. 2003 ; 77 (1). 221-225